Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Mi Jeong | - |
dc.contributor.author | Kim, Ryong Nam | - |
dc.contributor.author | Song, Kyoung | - |
dc.contributor.author | Jeon, Sinyoung | - |
dc.contributor.author | Jeong, Hae Min | - |
dc.contributor.author | Kim, Joo Seok | - |
dc.contributor.author | Han, Jinil | - |
dc.contributor.author | Hong, Sungyoul | - |
dc.contributor.author | Oh, Ensel | - |
dc.contributor.author | Choi, Jong-Sun | - |
dc.contributor.author | An, Jungsuk | - |
dc.contributor.author | Pollack, Jonathan R. | - |
dc.contributor.author | Choi, Yoon-La | - |
dc.contributor.author | Park, Cheol-Keun | - |
dc.contributor.author | Shin, Young Kee | - |
dc.date.available | 2020-02-27T16:42:42Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-11-03 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5472 | - |
dc.description.abstract | Gastric cancer (GC), one of the most common cancers worldwide, has a high mortality rate due to limited treatment options. Identifying novel and promising molecular targets is a major challenge that must be overcome if treatment of advanced GC is to be successful. Here, we used comparative genomic hybridization and gene expression microarrays to examine genome-wide DNA copy number alterations (CNAs) and global gene expression in 38 GC samples from old and young patients. We identified frequent CNAs, which included copy number gains on chromosomes 3q, 7p, 8q, 20p, and 20q and copy number losses on chromosomes 19p and 21p. The most frequently gained region was 7p21.1 (55%), whereas the most frequently deleted region was 21p11.1 (50%). Recurrent highly amplified regions 17q12 and 7q31.1-7q31.31 harbored two well-known oncogenes: ERBB2 and MET. Correlation analysis of CNAs and gene expression levels identified CAPZA2 (co-amplified with MET) and genes GRB7, MIEN1, PGAP3, and STARD3 (co-amplified with ERBB2) as potential candidate cancer-promoting genes (CPGs). Public dataset analysis confirmed co-amplification of these genes with MET or ERBB2 in GC tissue samples, and revealed that high expression (except for PGAP3) was significantly associated with shorter overall survival. Knockdown of these genes using small interfering RNA led to significant suppression of GC cell proliferation and migration. Reduced GC cell proliferation mediated by CAPZA2 knockdown was attributable to attenuated cell cycle progression and increased apoptosis. This study identified novel candidate CPGs co-amplified with MET or ERBB2, and suggests that they play a functional role in GC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.subject | PHASE-3 TRIAL | - |
dc.subject | TUMOR-SUPPRESSOR | - |
dc.subject | 17Q12 AMPLICON | - |
dc.subject | CELL INVASION | - |
dc.subject | EXPRESSION | - |
dc.subject | ADENOCARCINOMA | - |
dc.subject | AMPLIFICATION | - |
dc.subject | PATTERNS | - |
dc.subject | OVEREXPRESSION | - |
dc.subject | PROGRESSION | - |
dc.title | Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000414606800032 | - |
dc.identifier.doi | 10.18632/oncotarget.21150 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.8, no.54, pp.92209 - 92226 | - |
dc.identifier.scopusid | 2-s2.0-85032660024 | - |
dc.citation.endPage | 92226 | - |
dc.citation.startPage | 92209 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 8 | - |
dc.citation.number | 54 | - |
dc.contributor.affiliatedAuthor | An, Jungsuk | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | gastric cancer | - |
dc.subject.keywordAuthor | DNA copy number alterations | - |
dc.subject.keywordAuthor | potential cancer-promoting genes | - |
dc.subject.keywordAuthor | ERBB2 | - |
dc.subject.keywordAuthor | MET | - |
dc.subject.keywordPlus | PHASE-3 TRIAL | - |
dc.subject.keywordPlus | TUMOR-SUPPRESSOR | - |
dc.subject.keywordPlus | 17Q12 AMPLICON | - |
dc.subject.keywordPlus | CELL INVASION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ADENOCARCINOMA | - |
dc.subject.keywordPlus | AMPLIFICATION | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordPlus | OVEREXPRESSION | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.